These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 20448207)

  • 1. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
    Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
    Zhao L; Li AQ; Zhou TF; Zhang MQ; Qin XM
    Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1130-41. PubMed ID: 25298426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
    Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
    Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection by exenatide: A novel mechanism via improving mitochondrial function involving the GLP-1 receptor/cAMP/PKA pathway.
    Chang G; Liu J; Qin S; Jiang Y; Zhang P; Yu H; Lu K; Zhang N; Cao L; Wang Y; Li Y; Zhang D
    Int J Mol Med; 2018 Mar; 41(3):1693-1703. PubMed ID: 29286061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways.
    Erdogdu O; Eriksson L; Xu H; Sjöholm A; Zhang Q; Nyström T
    J Mol Endocrinol; 2013 Apr; 50(2):229-41. PubMed ID: 23343509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
    Sangle GV; Lauffer LM; Grieco A; Trivedi S; Iakoubov R; Brubaker PL
    Endocrinology; 2012 Feb; 153(2):564-73. PubMed ID: 22186413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor.
    Erdogdu O; Nathanson D; Sjöholm A; Nyström T; Zhang Q
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):26-35. PubMed ID: 20452396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.
    Hausenloy DJ; Whittington HJ; Wynne AM; Begum SS; Theodorou L; Riksen N; Mocanu MM; Yellon DM
    Cardiovasc Diabetol; 2013 Oct; 12():154. PubMed ID: 24148218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Nrf2 contributes to the protective effect of Exendin-4 against angiotensin II-induced vascular smooth muscle cell senescence.
    Zhou T; Zhang M; Zhao L; Li A; Qin X
    Am J Physiol Cell Physiol; 2016 Oct; 311(4):C572-C582. PubMed ID: 27488664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Neuroprotective Effect of Liraglutide is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP/PKA/CREB Pathway.
    Bao Y; Jiang L; Chen H; Zou J; Liu Z; Shi Y
    Cell Physiol Biochem; 2015; 36(6):2366-78. PubMed ID: 26279440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
    Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
    Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
    Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
    Li Y; Tweedie D; Mattson MP; Holloway HW; Greig NH
    J Neurochem; 2010 Jun; 113(6):1621-31. PubMed ID: 20374430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sitagliptin attenuates intestinal ischemia/reperfusion injury via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1 receptor-dependent manner.
    Khedr RM; Ahmed AAE; Kamel R; Raafat EM
    Life Sci; 2018 Oct; 211():31-39. PubMed ID: 30195035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism.
    Ishii M; Shibata R; Kondo K; Kambara T; Shimizu Y; Tanigawa T; Bando YK; Nishimura M; Ouchi N; Murohara T
    J Biol Chem; 2014 Sep; 289(39):27235-27245. PubMed ID: 25100725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
    Hui H; Nourparvar A; Zhao X; Perfetti R
    Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.
    Wei R; Ma S; Wang C; Ke J; Yang J; Li W; Liu Y; Hou W; Feng X; Wang G; Hong T
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E947-57. PubMed ID: 27072494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.